CCL5 and chronic kidney disease: Our results confirm that systemic administration of BPA in mice induces the renal gene expression of proinflammatory and chemotactic mediators such as Il-6, Ccl-2/MCP-1 and Ccl-5/Rantes, and this inflammatory response is aggravated in CKD mice, contributing to poor renal prognosis.